A team from @MonashPharmSci (MIPS) has partnered with @MSFTResearch AI for Science to enhance GPCR-related drug discovery. Led by @ppelvazhao , @denise_wootten and @PatrickMSexton1, the team is aiming to develop an AI model that can predict the clinical impact of receptor polymorphisms on diabetes treatments. Read more: #Microsoft #MIPS #AI #DrugDiscovery #Healthcare #Innovation

Bravo to the @MIPS_Australia-led team behind an @nhmrc Development grant focused on improving life expectancy in people living with pulmonary arterial hypertension (PAH) 🙌👇

Congratulations to the @MIPS_Australia researchers to be awarded $7.8m (total) funding through the latest @nhmrc Ideas Grants scheme 👏👏👇

Check out @normanswan & @teegstar discussing new @MIPS_Australia-led research on addressing COVID immune imprinting @ColinPouton @harry_wasity @TheDohertyInst 👇 (starts at 5:18)

The @MIPS_Australia team behind Australia’s first mRNA vaccine have published a study on how the vaccine could tackle COVID ‘immune imprinting’. Published in collab with @TheDohertyInst 👇 @ColinPouton @harry_wasity @dfjp

Congratulations to @CarlkRx who has been named a 2024 @BritPharmSoc Fellow. Bravo for the very well-deserved recognition! 👏👏👇

Congratulations to the brilliant @rebeccahritchie who has been named a 2024 @ASCEPTanz Fellow - the highest honour the Society bestows upon its members 🙌👏👇

Congratulations to the outstanding researchers behind the 10 MIPS-led projects to receive funding through the 2025 @arc_gov_au Discovery Projects scheme 👏👇

NEW STUDY: @MIPS_Australia researchers, in collab with @Monash_FMNHS and @ucddublin, have discovered that a natural fat molecule called ‘lipoxin A4’ (LXA4) could significantly reduce inflammation and improve function for diabetic hearts 👇

Congratulations to Arthur Christopoulos, Chris Porter, @PatrickMSexton1 and @NatalieTrevaski who have been named among the top 1% of scientists by citations in the 2024 @Clarivate HiCi researcher list 👏👇

Congratulations to Prof. Chris Porter, Director of @MIPS_Australia, on being appointed a Sir John Monash Distinguished Professor by @MonashUni in recognition of his exceptional contributions to research & commercialisation👏👏👇

Guests included South Korea’s @yonsei_u + The Korea Health Industry Development Institute, along with @MTPConnect_AUS and #mRNA Victoria

Congrats to the @MIPS_Australia & @YaleMed team behind $4M AUD in funding from the @ARPA_H #SprintForWomensHealth to drive forward a new treatment for ischemic stroke. Led by @NatalieTrevaski and Pro. Anne Eichmann, @YaleMed 👏👇

@SeaportTx has announced a $225M oversubscribed Series B financing round to advance the capabilities of the Glyph technology platform, initially invented by @MonashUni @MIPS_Australia researchers 👇

Congratulations to @BenBoyd_Monash who has been named the 2024 recipient of @AAPSComms prestigious Dale E. Wurster Research Award for significant contributions to drug delivery 👏👏👇

Always great to see our PhD stars sharing their research with @DrShaneRRR on @einstein_agogo. Check out @dominikafuhs chatting about data modelling to predict antimicrobial resistance: (interview starts at 19:57)

Medicines are essential for treating many diseases, but what about their environmental impact? Out now in @ConversationEDU, @laurentmay and Manuela Jorg unpack what needs to happen for greener drug design to become the way of the future 👇

RT @MonashBDI: 1/Paving the way for possible new treatments of diseases triggered by abnormal cell growth,research published in @Nature, co…

Out now in @Nature, @MIPS_Australia and @MonashBDI have solved the structure of human cell regulator ‘LYCHOS’, opening up an exciting new drug target for cancer and neurological diseases 👏👇